Literature DB >> 24676768

In vivo Toxicity Assessment of Antimicrobial Peptides (AMPs LR14) Derived from Lactobacillus plantarum Strain LR/14 in Drosophila melanogaster.

Ruchi Gupta1, Surajit Sarkar, Sheela Srivastava.   

Abstract

Lactic acid bacteria are known to produce antimicrobial peptides (AMPs) such as bacteriocins which can be employed to control pathogens and food spoilage microorganisms. However, their possible role as toxic agents against a eukaryotic system still remains unexplored. The present study deals with the in vivo evaluation of acute toxic effect of AMPs LR14, a mixture of AMPs isolated from Lactobacillus plantarum LR/14 on Drosophila melanogaster. The fly was used as a model system to measure the extent of toxicity of these peptides. The results showed that concentrations below 10 mg/ml are not significantly effective. When exposed to 10 mg/ml of AMPs LR14, acute toxic effect and a significant delay in the developmental cycle of the fly could be observed. Also, the weight and size of the flies were significantly reduced upon ingestion of these peptides. Higher concentrations (beyond 15 mg/ml) exerted a strong larvicidal effect. Detailed analysis on larval tissues and adult germ cells of the insect revealed deformity in cellular architecture, DNA fragmentation, and premature apoptosis, confirming that the peptides have a dose-dependent toxic property. Our studies provide the first information on the role of AMPs LR14 as an insecticidal agent.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24676768     DOI: 10.1007/s12602-013-9154-y

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  25 in total

1.  Effects of beta-cyfluthrin on white and sepia mutants of Drosophila melanogaster.

Authors:  Gireesh Nadda; Prabhu N Saxena; Garima Srivastava
Journal:  J Environ Biol       Date:  2005-06

Review 2.  Bacteriocin-based strategies for food biopreservation.

Authors:  Antonio Gálvez; Hikmate Abriouel; Rosario Lucas López; Nabil Ben Omar
Journal:  Int J Food Microbiol       Date:  2007-06-12       Impact factor: 5.277

Review 3.  Using Drosophila as a model insect.

Authors:  D Schneider
Journal:  Nat Rev Genet       Date:  2000-12       Impact factor: 53.242

4.  Reduction of Escherichia coli population following treatment with bacteriocins from lactic acid bacteria and chelators.

Authors:  C Belfiore; P Castellano; G Vignolo
Journal:  Food Microbiol       Date:  2006-09-05       Impact factor: 5.516

Review 5.  Human disease models in Drosophila melanogaster and the role of the fly in therapeutic drug discovery.

Authors:  Udai Bhan Pandey; Charles D Nichols
Journal:  Pharmacol Rev       Date:  2011-03-17       Impact factor: 25.468

Review 6.  Potential of bacteriocin-producing lactic acid bacteria for improvements in food safety and quality.

Authors:  L O'Sullivan; R P Ross; C Hill
Journal:  Biochimie       Date:  2002 May-Jun       Impact factor: 4.079

7.  Investigation of the cytotoxicity of eukaryotic and prokaryotic antimicrobial peptides in intestinal epithelial cells in vitro.

Authors:  Sam Maher; Siobhán McClean
Journal:  Biochem Pharmacol       Date:  2006-03-13       Impact factor: 5.858

8.  Purification and characterization of plantaricin LR14: a novel bacteriocin produced by Lactobacillus plantarum LR/14.

Authors:  Santosh Kumar Tiwari; Sheela Srivastava
Journal:  Appl Microbiol Biotechnol       Date:  2008-05-22       Impact factor: 4.813

9.  Adverse effect of organophosphate compounds, dichlorvos and chlorpyrifos in the reproductive tissues of transgenic Drosophila melanogaster: 70kDa heat shock protein as a marker of cellular damage.

Authors:  Subash C Gupta; Hifzur R Siddique; Neeraj Mathur; Ranjit K Mishra; Kalyan Mitra; Daya K Saxena; Debapratim K Chowdhuri
Journal:  Toxicology       Date:  2007-05-24       Impact factor: 4.221

Review 10.  The digestive tract of Drosophila melanogaster.

Authors:  Bruno Lemaitre; Irene Miguel-Aliaga
Journal:  Annu Rev Genet       Date:  2013       Impact factor: 16.830

View more
  7 in total

1.  In Vivo Assessment of Immunogenicity and Toxicity of the Bacteriocin TSU4 in BALB/c Mice.

Authors:  Tapasa Kumar Sahoo; Prasant Kumar Jena; Bhumika Prajapati; Laxita Gehlot; Amiya Kumar Patel; Sriram Seshadri
Journal:  Probiotics Antimicrob Proteins       Date:  2017-09       Impact factor: 4.609

2.  Characterization, Toxicity, and Optimization for the Growth and Production of Bacteriocin-like Substances by Lactobacillus curvatus.

Authors:  Graciele Daiana Funck; Juliana de Lima Marques; Guilherme da Silva Dannenberg; Claudio Eduardo Dos Santos Cruxen; Carla Pohl Sehn; Marina Prigol; Márcia Rósula Poetini Silva; Wladimir Padilha da Silva; Ângela Maria Fiorentini
Journal:  Probiotics Antimicrob Proteins       Date:  2020-03       Impact factor: 4.609

3.  Assessment of anti-plasmodial activity of non-hemolytic, non-immunogenic, non-toxic antimicrobial peptides (AMPs LR14) produced by Lactobacillus plantarum LR/14.

Authors:  Ruchi Gupta; Vinoth Rajendran; Prahlad C Ghosh; Sheela Srivastava
Journal:  Drugs R D       Date:  2014-06

Review 4.  A Review: The Fate of Bacteriocins in the Human Gastro-Intestinal Tract: Do They Cross the Gut-Blood Barrier?

Authors:  Leon M T Dicks; Leané Dreyer; Carine Smith; Anton D van Staden
Journal:  Front Microbiol       Date:  2018-09-28       Impact factor: 5.640

Review 5.  Bacteriocins: An Overview of Antimicrobial, Toxicity, and Biosafety Assessment by in vivo Models.

Authors:  Diego Francisco Benítez-Chao; Angel León-Buitimea; Jordy Alexis Lerma-Escalera; José Rubén Morones-Ramírez
Journal:  Front Microbiol       Date:  2021-04-15       Impact factor: 5.640

6.  Subchronic Oral Dose Toxicity Study of Enterococcus Faecalis 2001 (EF 2001) in Mice.

Authors:  Yeun-Hwa Gu; Takenori Yamasita; Ki-Mun Kang
Journal:  Toxicol Res       Date:  2018-01-15

7.  Evaluation of in vivo anti-malarial potential of omidun obtained from fermented maize in Ibadan, Nigeria.

Authors:  Favour O Omeiza; George O Ademowo; Funmilola A Ayeni
Journal:  Malar J       Date:  2020-11-19       Impact factor: 2.979

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.